Concert Pharmaceuticals CEO Roger Tung's 2018 pay jumps 34% to $4.6M

Concert Pharmaceuticals reports 2018 executive compensation

By ExecPay News

Published: April 29, 2019

Concert Pharmaceuticals reported fiscal year 2018 executive compensation information on April 29, 2019.
In 2018, three executives at Concert Pharmaceuticals received on average a compensation package of $3M, a 22% increase compared to previous year.
Average pay of disclosed executives at Concert Pharmaceuticals
2013201420152016201720182019202020210750K1.5M2.3M3M
  • Salary
  • Stock
  • Options
  • Non-Equity Incentive
  • Bonus
  • Other
Roger D. Tung, Chief Executive Officer, received $4.6M in total, which increased by 34% compared to 2017. 82% of Tung's compensation, or $3.8M, was in option awards. Tung also received $300K in non-equity incentive plan, $536K in salary, as well as $10K in other compensation.
Marc Becker, Chief Financial Officer, received a compensation package of $2.5M. 77% of the compensation package, or $1.9M, was in option awards.
Nancy Stuart, Chief Operating Officer, earned $1.9M in 2018, a 2% decrease compared to previous year.

Related executives

Roger Tung

Concert Pharmaceuticals

Chief Executive Officer

Nancy Stuart

Concert Pharmaceuticals

Chief Operating Officer

Marc Becker

Concert Pharmaceuticals

Chief Financial Officer

You may also like

Source: SEC filing on April 29, 2019.
0